Our recent announcements and latest news
Premier Research’s staff across the United States took part in National Lemonade Days on Friday June 8, 2012. Employees in Austin, Phoenix, Philadelphia, Quincy and Salt Lake City set up lemonade stands at their office locations to raise funds for Alex’s Lemonade Stand Foundation (ALSF).
New Survey Reveals Companies’ Concerns About Too Few Pediatric Patients for Clinical Trials Premier Research’s Survey Also Reveals Confusion About PREA and Its EU Counterpart
A new biopharma survey of 55 biotech and pharmaceutical firms in both the North America and European markets by Premier Research reveals that the biggest problem those companies are facing in complying with pediatric regulations is that there may not be enough children who are both accessible and can meet often stringent study criteria to participate in the required clinical trials.
Premier Research participated at the ACRP 2012 Global Conference, April 16-18 in Houston, Texas. Dr. Charlene Sanders, M.D., Vice President, Global Regulatory Affairs & Pediatric Strategic Consulting and Angi Robinson, Executive Director, Clinical Trials Management led a session entitled “Successful Pediatric Studies: Key Study Design and Site Selection Considerations.”
Premier Research Group announces the appointment of Sean Russell to the position of Vice President, Marketing. In this position, Mr. Russell will have global responsibility for leading and developing global marketing at Premier Research.
Premier Research Group announces the appointment of Etienne Drouet to the position of Executive Director, Oncology Europe. In this position, Mr. Drouet will play a leading role in the operations, strategic planning and corporate development of Premier Research’s growing portfolio of oncology business.
Premier Research Names Susan Stansfield, Ph.D. Executive VP, Clinical Development, Strengthens Premier’s Operational Delivery on Worldwide Projects
Premier Research Group announces the appointment of Susan C. Stansfield, Ph.D. to the position of Executive Vice President, Clinical Development. In this position, Dr. Stansfield will have global responsibility for leading and developing the company’s clinical trial management services provided to the biopharmaceutical industry.